Methods and Materials for the Detection of Leishmania Infection

a technology of leishmania and detection methods, applied in the field of leishmania diagnosis, can solve the problems of lack of sensitivity and specificity of tests, and the current diagnostic procedures are not readily applicable to field situations, and achieve the effect of rapid treatmen

Inactive Publication Date: 2009-12-24
INBIOS INT
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0009]The present invention provides rapid diagnostic assays for the detection of Leishmania amastigotes, promastigotes and/or secreted proteins which can readily be used in the field, leading to more rapid treatment. In one embodiment, the present invention provides diagnostic tests, including ELISA and lateral flow assays, that may be effectively employed to detect a Leishmania major antigen that is present in both promastigotes grown in culture and, more importantly, in amastigotes—the form present in cutaneous lesions. Such assays may be employed to detect th

Problems solved by technology

For example, leishmaniasis may be manifested as a cutaneous disease, which is a severe medical problem.
Current diagnostic procedures are not readily applicable to field situations and typically require centralized

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and Materials for the Detection of Leishmania Infection
  • Methods and Materials for the Detection of Leishmania Infection
  • Methods and Materials for the Detection of Leishmania Infection

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of Monoclonal Antibodies to Leishmania Amastigotes

[0048]Amastigotes for immunization were isolated from non-necrotic lesions at the dorsal part of the tail base in L. major RM2-infected RAG2− / − mice approximately 4 to 5 weeks after infection. The sonicated amastigotes were centrifuged at 1,600 g for 30 min at 4° C. and the resulting supernatants were used as antigens. BALB / c mice were immunized with whole lysate of amastigotes with complete Freund's adjuvant. After the first immunization, the mice were inoculated with the same dose of amastigote homogenate every 3 weeks. The mice were given a final boost of amastigote homogenate 4 days before fusion. Hybrid cells were produced by fusing P3-X63-Ag8-U1 cells with spleen cells isolated from the immunized mice. Hybridomas were screened for production of antibodies against amastigote antigens by ELISA. Limiting dilution was performed twice to obtain monoclonal hybridomas. One of the hybridomas, referred to as C11C, was inocul...

example 2

Preparation of Monoclonal and Polyclonal Antibodies to Recombinant TSA

[0049]Recombinant TSA expressed in E. coli was used as immunogen for preparing additional monoclonal antibodies in mice and for raising a polyclonal antibody in rabbits. Supernatants from four monoclonal antibodies were tested for their reactivity against TSA and an unrelated T. cruzi protein as negative control. In addition, the rabbit polyclonal antibody was affinity purified on a TSA sepharose column for use in ELISA and rapid test development.

example 3

Reactivity of Antibodies Against L. Major Amastigotes and Promastigotes

[0050]Various antibodies, including C11C, were analyzed to determine their reactivity with solubilized preparations of L. major promastigotes grown in culture, as well as with amastigotes derived from skin lesions of mice infected with L. major. These studies enabled the selection of antibodies / target antigens that reacted with both forms of L. major but with particular emphasis on amastigotes, the form present in skin lesions. We initially analyzed antibodies to test their reactivity / titer with a fixed concentration of antigen on an ELISA plate and then, using a fixed dilution, determined what level of antigen could be detected in both L. major promastigotes and amastigotes, the latter being derived from skin lesions from infected mice. Polyclonal antibodies used in these initial studies were against L. major amastigotes, TSA, LmSTI1 (M15), HSP83 (JV91), HSP70 (JV8E), LACK antigen and a secreted polyprotein from...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides rapid diagnostic assays for the detection of Leishmania which can readily be used in the field, leading to more rapid treatment. In certain embodiments, the inventive assays, including ELISA and lateral flow assays, employ antibodies that may be effectively employed to detect the Leishmania major antigen TSA, which is present in both promastigotes grown in culture and in amastigotes. Such assays may be employed to detect the presence of cutaneous leishmaniasis in a subject using scrapings, biopsies, and/or aspirates taken from cutaneous lesions.

Description

REFERENCE TO PRIORITY APPLICATION[0001]This application claims priority to U.S. provisional patent application No. 60 / 742,761, filed Dec. 6, 2005.STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT[0002]The U.S. Government has a paid-up license in this invention and the right in limited circumstances to require the patent owner to license others on reasonable terms as provided for by the terms of Grant No. W81XWH-05-C-0018 awarded by the Department of Defense.FIELD OF THE INVENTION[0003]The present invention relates generally to the diagnosis of Leishmania infection. More specifically, the invention relates to the immunological detection of cutaneous leishmaniasis.BACKGROUND OF THE INVENTION[0004]Leishmania organisms are intracellular protozoan parasites of macrophages that cause a wide range of clinical diseases in humans and domestic animals, primarily dogs. The life cycles of Leishmania involves a vertebrate host (e.g., a human) and a vector (a sand fly) that transmit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N33/00G01N33/53
CPCG01N33/56905Y02A50/30
Inventor HOUGHTON, RAYMOND L.REED, STEVEN G.RAYCHAUDHURI, SYAMAL
Owner INBIOS INT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products